Viatris Inc. (VTRS)

Viatris to Receive $400 Million in Cash and $415 Million in Equity Shares of Biocon Limited Transaction Accelerates the Expiration of Biosimilars Non-Compete Restrictions PITTSBURGH , Dec. 6, 2025 /PR...

Viatris (VTRS) and Teva Pharma (TEVA) could soon face fresh competition after billionaire entrepreneur Mark Cuban called on Washington to scrap a fee he says is...

Viatris Inc. (VTRS) Presents at Evercore 8th Annual Healthcare Conference Transcript...

Viatris Inc. (VTRS) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript...

Management to Participate in 8th Annual Evercore Annual Healthcare Conference Management to Participate in 8th Annual Evercore Annual Healthcare Conference...

PITTSBURGH , Nov. 24, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS), a global healthcare company, today announced that the Company will participate in two upcoming healthcare conferences in Decembe...

/PRNewswire/ - S príchodom Svetového týždňa povedomia o antimikrobiálnej rezistencii (AMR) uvádza Svetová zdravotnícka organizácia vo svojej Globálnej správe o...

/PRNewswire/ -- Zu Beginn der Weltwoche zur Sensibilisierung für Antibiotikaresistenzen (AMR) zeigt der globale Bericht der Weltgesundheitsorganisation zur...

/PRNewswire/ -- Wraz z rozpoczęciem Światowego Tygodnia Wiedzy o Antybiotykach (World AMR Awareness Week) raport Światowej Organizacji Zdrowia z 2025 r. na...

Viatris Inc. ( VTRS ) Jefferies London Healthcare Conference 2025 November 18, 2025 6:30 AM EST Company Participants Scott Smith - CEO & Director Theodora Mistras - Chief Financial Officer Philippe Ma...